Evidence map›Paper›PMID 29118244›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Isolation and Characterization of Antigen-Specific Plasmablasts Using a Novel Flow Cytometry-Based Ig Capture Assay.

Christopher L Pinder, Sven Kratochvil, Deniz Cizmeci, Luke Muir, Yanping Guo, Robin J Shattock, Paul F McKay

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Christopher L PinderDivision of Medicine, Department of Infectious Diseases, Imperial College London, London W2 1PG, United Kingdom; and.ORCID 0000-0003-4149-226X
Sven KratochvilDivision of Medicine, Department of Infectious Diseases, Imperial College London, London W2 1PG, United Kingdom; and.ORCID 0000-0002-0446-2371
Deniz CizmeciDivision of Medicine, Department of Infectious Diseases, Imperial College London, London W2 1PG, United Kingdom; and.
Luke MuirDivision of Medicine, Department of Infectious Diseases, Imperial College London, London W2 1PG, United Kingdom; and.ORCID 0000-0002-7834-6066
Yanping GuoFlow Cytometry Core Facility, National Heart and Lung Institute, Imperial College London, London W2 1PG, United Kingdom.
Robin J ShattockDivision of Medicine, Department of Infectious Diseases, Imperial College London, London W2 1PG, United Kingdom; and p.mckay@imperial.ac.uk r.shattock@imperial.ac.uk.
Paul F McKayDivision of Medicine, Department of Infectious Diseases, Imperial College London, London W2 1PG, United Kingdom; and p.mckay@imperial.ac.uk r.shattock@imperial.ac.uk.
Imperial College London · GBLung Institute · US

Funding

Wellcome Trust 083844Wellcome Trust 102413
6 · The paper itself

Abstract

We report the development of a novel flow cytometry-based Ig capture assay (ICA) for the identification and sorting of individual Ab-secreting cells based on their Ag reactivity. The ICA represents a fast and versatile tool for single-cell sorting of peripheral plasmablasts, streamlining subsequent Ab analysis, and cloning. We demonstrate the utility of the assay by isolating Ag-reactive plasmablasts from cryopreserved PBMC obtained from volunteers vaccinated with a recombinant HIV envelope protein. To show the specificity of the ICA, we produced Ag-specific Abs from these cells and subsequently verified their Ag reactivity via ELISA. Furthermore, we used the ICA to track Ag-specific plasmablast responses in HIV-vaccine recipients over a period of 42 d and performed a head-to-head comparison with a conventional B cell ELISpot. Results were highly comparable, highlighting that this assay is a viable alternative for monitoring Ag-specific plasmablast responses at early time points after infection or vaccination. The ICA provides important added benefits in that phenotypic information can be obtained from the identified Ag-specific cells that can then be captured for downstream applications such as B cell sequencing and/or Ab cloning. We envisage the ICA as being a useful tool in Ab repertoire analysis for future clinical trials.

Indexed as

AIDS VaccinesAntibodies, BacterialAntigen-Antibody ReactionsAntigens, BacterialBlood PreservationCell SeparationCryopreservationenv Gene Products, Human Immunodeficiency VirusEnzyme-Linked Immunospot AssayFlow CytometryFollow-Up StudiesHEK293 CellsHepatitis B Surface AntigensHepatitis B VaccinesHIV AntibodiesHumansAIDS VaccinesAntibodies, BacterialAntigens, Bacterialenv Gene Products, Human Immunodeficiency Virusgp140 envelope protein, Human immunodeficiency virus 1Hepatitis B Surface AntigensHepatitis B VaccinesHIV AntibodiesPeptide FragmentsTetanus Toxintetanus toxin fragment CTetanus Toxoid

Identifiers

PMID29118244
PMCPMC5720343
OpenAlexW2767477047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.